Analysts at SVB Leerink started coverage on shares of Ardent Health Partners (NYSE:ARDT – Get Free Report) in a report issued on Monday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $23.00 price target on the stock. SVB Leerink’s target price would suggest a potential upside of 43.21% from the stock’s previous close.
Separately, Truist Financial assumed coverage on shares of Ardent Health Partners in a research note on Monday. They set a “buy” rating and a $21.00 price target on the stock. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Ardent Health Partners currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.70.
View Our Latest Stock Analysis on Ardent Health Partners
Ardent Health Partners Stock Down 0.4 %
About Ardent Health Partners
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Further Reading
- Five stocks we like better than Ardent Health Partners
- Energy and Oil Stocks Explained
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- What is a Death Cross in Stocks?
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- Bank Stocks – Best Bank Stocks to Invest In
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.